Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 13 Weeks

17-Dec-18 - 17-Mar-19
Buy Ratio:24%

Down

# Net Buyers:50
# Net Sellers:161

Previous 13 Weeks

17-Sep-18 - 16-Dec-18
Buy Ratio:31%
# Net Buyers:65
# Net Sellers:142
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Endocyte Inc--$144.10M  
Lilly Eli & Co($110.22M)$91.85M  
Chemocentryx, Inc.($2.46M)$84.01M  
Intercept Pharmaceuticals, Inc.($5.09M)$81.04M  
Regeneron Pharmaceuticals, Inc.($54.78M)$56.73M  
New Net Buyers
CompanyNet Buy AmountChange
Acceleron Pharma Inc$29.53M$30.21M  
Alder Biopharmaceuticals Inc$20.00M$20.94M  
Esperion Therapeutics, Inc.$6.32M$10.34M  
Kindred Biosciences, Inc.$6.13M$7.82M  
Pacira Biosciences, Inc.$66.24K$7.78M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Tesaro, Inc.($3.37B)($3.36B)  
Loxo Oncology, Inc.($561.91M)($547.21M)  
Corium International, Inc.--($299.40M)  
Spark Therapeutics, Inc.($240.49M)($240.49M)  
Mirati Therapeutics, Inc.($156.95M)($156.95M)  
New Net Sellers
CompanyNet Buy AmountChange
Jazz Pharmaceuticals Plc($5.36M)($11.27M)  
Heska Corp($8.02M)($9.94M)  
Amicus Therapeutics, Inc.($4.11M)($4.61M)  
Achaogen, Inc.($2.12M)($4.07M)  
Apollo Endosurgery, Inc.($2.25M)($3.95M)